Venaxis shares surged 12.15 percent on more than twelve times the average daily volume Monday to close at $2.40 a share. Analysts at Canaccord have upgraded the company’s rating from “hold” to “buy” and have raised its price target to $7.00 citing.
Going forward ... (see research report)
Copyright ® 2014. The Bedford Report. All Rights Reserved.